Suppliers
Just as we believe that good health is the foundation of vibrant lives, thriving communities and forward progress, at Johnson & Johnson we also pride ourselves on fostering healthy supplier relationships that are built on trust, transparency and unparalleled innovation, quality and reliability.
Working with our valued partners, we uphold the highest standards for responsible sourcing and corporate citizenship, encouraging our suppliers to embrace new technologies, source innovative solutions and deliver new business models that contribute to our mutual objectives for growth, sustainability and streamlined processes.
Expand
Collapse
Featured stories
How Johnson & Johnson is helping people displaced by war and conflict restart their lives
A Partnership for Good program expands the company’s talent pool in Europe while assisting the mental and financial health of people displaced by conflict. Here’s how this novel initiative helped one young Ukraine War refugee get a foothold.
Turning our supplier spend into societal good
Johnson & Johnson’s Global Supplier Diversity & Inclusion team is stepping up spending with social enterprises around the world to deepen its impact in local communities.
Securing the future of surgery, one staple at a time
Faced with the challenge of improving stapling performance for consistent outcomes in challenging tissue, Ethicon drew inspiration from its broad and talented supplier base.
At Johnson & Johnson, our goal is to collaborate with our 38,500 suppliers around the world and use our collective ingenuity to change the trajectory of health for humanity.
Shashi Mandapaty
Chief Procurement Officer, Johnson & Johnson
More from Johnson & Johnson
What to know about We All Belong: 2023 DEI Impact Review
The annual report details how Johnson & Johnson is harnessing the power of diversity, equity and inclusion to provide better care around the world.
Giving the gift of sight
In Kenya, around 1.5 million people—including children—contend with visual impairment or blindness. Sight For Kids, Johnson & Johnson’s global eye-care partnership, is devoted to changing these stats, one vision screening at a time.
Inside the development of a revolutionary treatment for blood cancers
In 2014, a Johnson & Johnson therapy gained approval for the treatment of a type of B-cell malignancy—increasing survival rates and changing the way scientists approach cancer treatment. These 8 milestone moments tell the transformational story.